You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,952,343


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,952,343
Title: HIV protease inhibitors
Abstract:HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
Inventor(s): Dressman; Bruce A. (Indianapolis, IN), Fritz; James E. (Greenwoode, IN), Hornback; William J. (Indianapolis, IN), Kaldor; Stephen W. (Indianapolis, IN), Kalish; Vincent J. (San Diego, CA), Munroe; John E. (Indianapolis, IN), Reich; Siegfried Heinz (San Diego, CA), Tatlock; John H. (Poway, CA), Shepherd; Timothy A. (Indianapolis, IN), Rodriguez; Michael J. (Indianapolis, IN)
Assignee: Agouron Pharmaceuticals, Inc. (
Application Number:08/481,831
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property protection, providing inventors with exclusive rights to their creations. In the United States, the patent system is governed by the U.S. Patent and Trademark Office (USPTO) and is subject to specific laws and regulations. This article delves into the scope and claims of U.S. patents, using the example of U.S. Patent 5,952,343 to illustrate key concepts.

What is a Patent?

A patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. Patents are indicators of invention and provide valuable technological and geographic details[1].

The Patenting Process

The process of obtaining a patent involves several steps, including the conception of the idea, reduction to practice, and the filing of a patent application. The application must list the "true and only" inventors, as incorrect or deceptive inventorship can render the patent unenforceable[2].

Claim Scope in Patent Applications

The claim scope is a critical aspect of a patent application. It defines the boundaries of what is protected by the patent. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate. The claim scope must be anchored to the embodiments disclosed in the specification to avoid invalidation grounds such as the abstract idea exception and failure to meet the written description requirement[3].

Importance of Proper Claim Scope

Proper claim scope is essential for the validity and enforceability of a patent. Overly broad claims can lead to invalidation, while claims that are too narrow may not provide sufficient protection. The claim scope should be tailored to the actual invention, considering factors like prior art, the client’s budget, and the technical field[3].

U.S. Patent 5,952,343: An Example

To illustrate these concepts, let's consider U.S. Patent 5,952,343, though the specific details of this patent are not provided here. Here is how the general principles apply:

Claim Structure

The claims in a patent like 5,952,343 would be structured to clearly define the invention. Each claim would specify the elements of the invention, and these elements must be supported by the description in the specification.

Claim Types

Patents can include various types of claims, such as independent claims, dependent claims, and method claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Scope Analysis

For a patent like 5,952,343, the claim scope would be analyzed to ensure it is neither too broad nor too narrow. This involves reviewing the prior art to ensure the claims are novel and nonobvious, and that they meet the written description requirement.

Patent Landscape and Trends

The patent landscape in the United States is dynamic, with trends reflecting technological advancements and economic shifts. Here are some key trends and aspects:

Technology Areas

Patents are classified into various technology areas, such as electrical engineering, mechanical engineering, and chemistry. The USPTO uses the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields. For example, electrical engineering patents, which include computer technology and digital communication, have seen significant growth between 2000 and 2018[1].

Patent Ownership

Patents can be owned by various entities, including businesses, individuals, academic institutions, and government sectors. In 2018, businesses received the majority of patents, with 85% of the total patents granted to U.S. assignees[1].

International Comparisons

The USPTO also provides data for international patents, allowing for comparisons across different countries. This helps in understanding global trends in invention and innovation[1].

Determining Inventorship

Correctly determining who should be listed as an inventor is crucial. Inventorship involves the conception of the idea and the reduction to practice. Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable[2].

The Role of the USPTO

The USPTO plays a central role in the patent system, providing resources such as Patent and Trademark Resource Centers (PTRCs) and the Electronic Official Gazette. These resources help inventors and patent practitioners in searching and analyzing patent data[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which would aim to provide a more accessible and cost-effective way for small inventors and businesses to resolve patent disputes. This initiative involves input from various stakeholders, including academic experts and legal practitioners[5].

Key Takeaways

  • Claim Scope: The claim scope in a patent application is critical and must be balanced to avoid invalidation.
  • Inventorship: Correctly determining the true and only inventors is essential for the validity of the patent.
  • Patent Trends: The patent landscape is influenced by technological advancements and economic factors.
  • USPTO Resources: The USPTO provides various resources to support inventors and patent practitioners.
  • Small Claims Court: There is ongoing discussion about establishing a small claims patent court to facilitate dispute resolution for smaller entities.

FAQs

Q: What is the importance of claim scope in a patent application?

A: The claim scope defines the boundaries of what is protected by the patent. It must be balanced to avoid being too broad, which can lead to invalidation, or too narrow, which may not provide sufficient protection.

Q: How is inventorship determined in a U.S. patent application?

A: Inventorship involves the conception of the idea and the reduction to practice. The true and only inventors must be listed in the patent application to ensure the patent's validity.

Q: What are the main technology areas for patents granted by the USPTO?

A: The main technology areas include electrical engineering, mechanical engineering, and chemistry, among others. These areas are classified under the WIPO system, which includes 35 technical fields.

Q: Why is it important to correctly identify inventors in a patent application?

A: Incorrect or deceptive inventorship can render the patent unenforceable. Ensuring the correct inventors are listed is crucial for the patent's validity.

Q: What resources does the USPTO provide for patent search and analysis?

A: The USPTO provides resources such as Patent and Trademark Resource Centers (PTRCs), the Electronic Official Gazette, and the Common Citation Document (CCD) application to support inventors and patent practitioners.

Sources

  1. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  2. Oregon State University. Determining Inventorship for US Patent Applications. [PDF]
  3. Rimon Law. The Importance of Getting the Claim Scope Right in a US Patent Application. October 4, 2021.
  4. U.S. Patent and Trademark Office. Search for patents.
  5. Administrative Conference of the United States. U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,952,343

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,952,343

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 600 ⤷  Subscribe
African Regional IP Organization (ARIPO) 9600844 ⤷  Subscribe
Austria 222240 ⤷  Subscribe
Austria 286025 ⤷  Subscribe
Austria 362918 ⤷  Subscribe
Australia 5252993 ⤷  Subscribe
Australia 694746 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.